SEC CIK 734383 · Series S000002922 · Portfolio as of 2026-07-31
| Security | Value | Weight |
|---|---|---|
| Eli Lilly & Co · LLY | $3.29B | 8.62% |
| Merck & Co Inc · MRK | $2.08B | 5.44% |
| Johnson & Johnson · JNJ | $1.84B | 4.83% |
| AstraZeneca PLC · AZN | $1.75B | 4.59% |
| UnitedHealth Group Inc · UNH | $1.55B | 4.05% |
| GSK PLC · GLAXF | $1.15B | 3.00% |
| Edwards Lifesciences Corp · EW | $977.6M | 2.56% |
| Intuitive Surgical Inc · ISRG | $963.0M | 2.52% |
| CVS Health Corp · CVS | $961.8M | 2.52% |
| Cencora Inc · COR | $944.6M | 2.48% |
From N-PORT Part B, units verified by net-asset reconciliation.
curl "https://api.fundlens.io/v1/funds/VGHCX/holdings" \
-H "x-api-key: your_api_key"Full holdings, every historical snapshot, point-in-time queries, monthly returns and flows — free tier available, no card required.
Source: SEC EDGAR Form N-PORT. Data is quarterly with a regulatory filing lag; this page shows the most recent public filing. Not investment advice.